Stay Informed on Corporate Sustainability

Explore industry news, insights, and updates from the Pharma Industry Awards.

Sort by

AbbVie invests $380 million in North Chicago manufacturing expansion

Author: Archie Villaflores

United States pharmaceutical manufacturer AbbVie will invest $380 million (€322 million) to construct two manufacturing facilities at its North Chicago campus. The plants will produce active pharmaceutical ingredients for obesity and neuroscience medications, creating 300 positions.

Gilead Sciences acquires CAR-T specialist Arcellx for $7.8 billion

Author: Archie Villaflores

United States-based pharmaceutical company Gilead Sciences has agreed to acquire CAR-T specialist Arcellx for $7.8 billion (€6.6 billion). The acquisition strengthens Gilead's manufacturing excellence capabilities in cell therapy production for blood cancer treatment.

Argent BioPharma completes largest CannEpil shipment to Ireland

Author: Archie Villaflores

Australia's Argent BioPharma has delivered its largest commercial shipment of CannEpil to Ireland, where the epilepsy treatment is fully reimbursed under National Health Insurance. The €467,000 shipment strengthens Ireland's pharmaceutical supply chain capabilities for neurological therapies.

DHL expands pharmaceutical cold chain network to include Ireland

Author: Archie Villaflores

DHL Group is expanding its dedicated airfreight cold chain network to Ireland and seven other countries to meet pharmaceutical transport demand. The €2 billion investment strengthens temperature-controlled logistics capabilities for biologics and cell and gene therapies.

Belfast drug discovery firm secures South Korean strategic investment

Author: Archie Villaflores

Belfast-based drug discovery company AMPLY Discovery has secured strategic investment from South Korean biotech firm Keeps Biomed. The partnership strengthens Northern Ireland's pharmaceutical manufacturing excellence capabilities and advances AI-driven oncology drug development.

Broadened Pipeline

Author: Archie Villaflores

Pharmaceutical sector growth is shaped by strategic acquisitions and research partnerships that extend commercial portfolios whilst strengthening supply chain resilience. Narcolepsy treatment consolidation, award recognition documentation, and medicinal plant collaboration converge to demonstrate sector dynamism. First, 'Pharma Industry Awards 2025 Book of the Night captures a defining evening for Irish pharma' preserves achievement narratives including AbbVie Ireland's dual category wins and Deciphex's AI-powered innovation recognition. This commemorative publication establishes benchmarks as the sector advances toward the upcoming 2026 awards. Additionally, 'Alkermes completes $2.3 billion acquisition of Avadel Pharmaceuticals' demonstrates how Irish biopharmaceutical companies consolidate commercial portfolios through cash-and-debt transactions adding FDA-approved narcolepsy treatments. Strategic acquisitions accelerate market entry whilst leveraging estimated populations of oxybate-eligible patients across significant growth opportunities. Meanwhile, 'BauerTek partners with Rizal Technological University on medicinal plant production' reflects how pharmaceutical manufacturers establish academic cultivation partnerships to secure traceable raw materials for supplement operations. Research collaboration optimises growing conditions and extraction processes whilst supporting knowledge transfer between industry and academia. These stories frame a sector where acquisition strategy, achievement documentation, and supply chain innovation determine competitive advantage. Explore each article to understand how acquisitions and partnerships are advancing pharmaceutical sector positioning.